In lung transplantation, we see patients with a variety of advanced lung diseases, each with unique challenges that require individualized treatments. Living with an advanced lung disease and going through the process of a lung transplant are not only physically demanding, but emotionally draining as well. Personally, I believe that successful treatment means a comprehensive approach, including state-of-the-art medical and surgical therapies, a collaborative team of experts and a personal touch to reassure each patient that we’ll do our very best to improve his or her health and well-being.
I truly enjoy working here at Ohio State. The people here are honest, open and very caring. We have a very family focused atmosphere, especially in regard to our lung transplant team.
When I’m not working, I like to spend time traveling and relaxing with my family. I also enjoy playing basketball, at least for as long as my body holds up!
- My primary research interest is the study of the lung microbiome, and specifically, the virome in lung transplantation and other pulmonary disorders
University of Texas Southwestern College of Medicine
6/21/2009 - 6/22/2011
Specialties and conditions I treat
- Pulmonary Disease
- Critical Care Medicine
- Lung Transplantation
- Pulmonary Medicine
- Lung Diseases
Locations where I practice
More about my work
7/1/2011 - 12/31/2015
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Pulmonary Disease)
Pulmonary, Allergy, Critical Care and Sleep Medicine
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Keller has reported no financial relationships with medical device, research and/or drug companies.